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Abstract
Chronic helminth infections, such as schistosomes, are negatively associated with allergic disorders. Here, using B cell IL-
10-deficient mice, Schistosoma mansoni-mediated protection against experimental ovalbumin-induced allergic airway
inflammation (AAI) was shown to be specifically dependent on IL-10-producing B cells. To study the organs involved, we
transferred B cells from lungs, mesenteric lymph nodes or spleen of OVA-infected mice to recipient OVA-sensitized mice,
and showed that both lung and splenic B cells reduced AAI, but only splenic B cells in an IL-10-dependent manner.
Although splenic B cell protection was accompanied by elevated levels of pulmonary FoxP3+ regulatory T cells, in vivo
ablation of FoxP3+ T cells only moderately restored AAI, indicating an important role for the direct suppressory effect of
regulatory B cells. Splenic marginal zone CD1d+ B cells proved to be the responsible splenic B cell subset as they
produced high levels of IL-10 and induced FoxP3+ T cells in vitro. Indeed, transfer of CD1d+ MZ-depleted splenic B cells
from infected mice restored AAI. Markedly, we found a similarly elevated population of CD1dhi B cells in peripheral blood
of Schistosoma haematobium-infected Gabonese children compared to uninfected children and these cells produced
elevated levels of IL-10. Importantly, the number of IL-10-producing CD1dhi B cells was reduced after anti-schistosome
treatment. This study points out that in both mice and men schistosomes have the capacity to drive the development of
IL-10-producing regulatory CD1dhi B cells and furthermore, these are instrumental in reducing experimental allergic
inflammation in mice.
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Introduction
The prevalence and severity of allergic diseases and asthma has
increased over the last five decades in industrialized countries [1].
Conversely, lower prevalence of allergic diseases is seen in low
income countries. Many epidemiological studies have reported an
inverse association between helminth infections, which are highly
prevalent in developing countries, and allergic or auto-immune
disorders [2–4]. In order to study the interaction between
helminth infections and protection against allergic diseases,
murine models of allergic airway inflammation (AAI) and
helminth infection have been developed. For example, H. polygyrus
or T. spiralis infections protected against house dust mite-induced
and/or ovalbumin (OVA)-specific AAI [5,6]. In addition, S.
mansoni infection protected mice against OVA-induced airway
hyperresponsiveness (AHR)[7]; protection was optimal during the
chronic stage of infection, but not the acute stage [8].
Helminth infections are characterized by potent type 2 effector
responses and a strong regulatory network [9]. Regulatory T
(Treg) cells are well-known for their suppressive capacity, but
recent studies in auto-immunity models have indicated that also B
cells can be important players in immune regulation [10]. These
so-called regulatory B cells are known to influence the immune
system by the regulatory cytokines IL-10 and TGF-b, influencing
T cell proliferation, downregulating CD4+, CD8+, NK T cell
activation and promoting FoxP3+ Treg cell induction [11].
Interestingly, a number of studies have reported that B cells may
have an active regulatory role in various parasitic infections. For
example, IL-10-producing B cells in L. major-infected BALB/c
mice are essential in suppressing type 1 responses that are
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necessary to clear infection [12] and S. mansoni-infected B cell-
deficient mMT mice show more extensive hepatic granulomas
[13]. In addition, in a model of systemic anaphylaxis or AAI, in
combination with S. mansoni infection with adult stage worms only,
B cells appeared to be major players in addition to IL-10 and Treg
cells [7,14].
In auto-immunity models several Breg subsets have been
identified, including marginal zone (MZ), transitional or
CD5+CD1dhi B cells [15]. Recent studies in human auto-immune
diseases have substantiated these findings by showing human Breg
cells in peripheral blood characterized as CD24hiCD38hi [16],
CD24hiCD27+[17] or CD1dhi B cells [18].
Here, we investigated both in mice and humans whether
schistosome infections can induce functional Breg cells. Indeed, we
identified for the first time in peripheral blood of S. haematobium-
infected children elevated numbers of IL-10-producing CD1dhi
regulatory B cells, which were decreased after treatment. The
functional capacity of those schistosome-induced Breg cells was
confirmed in a mouse model of allergic airway inflammation
where Breg-derived IL-10 and Breg-induced Treg cells mediated
suppression.
Materials and Methods
Ethics statement
Mice were housed under SPF conditions at the animal facilities
of the Leiden University Medical Center in Leiden, the Nether-
lands. All animal studies were performed in accordance with the
guidelines and protocols (DEC-07062, 07152, 08034, 09141)
approved by the Ethics Committee for Animal Experimentation of
the University of Leiden, The Netherlands. The human study was
conducted according to the principles expressed in the Declaration
of Helsinki. The study was approved by the ‘‘Comite´ d’Ethique
Regional Independent de Lambare´ne´’’ (CERIL). Written in-
formed consent was obtained from parents or legal guardians of
children participating in the study.
Animals
Six week-old female C57/Bl6 OlaHsd mice were purchased
from Harlan. For the generation of chimeric IL-10-producing B
cell-deficient mice, B cell-deficient mMT mice were irradiated to
remove the bone marrow (BM). Subsequently, the irradiated mice
were reconstituted with 80% of mMT BM and 20% IL-102/2 BM
cells (IL-10-deficient) or with 80% of mMT BM and 20% wild-type
(WT) BM as described [10]. DEREG (DEpletion of REGulatory T
cells) mice were kindly provided by Dr. T. Sparwasser [19].
Parasitic infection and AAI induction
Mice were infected percutaneously with 40 S. mansoni cercariae
and the infection lasted until 14 weeks (chronic phase starts around
week 12)[8]. For AAI induction, mice were sensitized twice by i.p.
injections of OVA (10 mg/mL, Worthington Biochemical Corp) in
Imject Alum (2 mg/ml; Pierce) at 17 and 10 days before challenge.
Sensitization was initiated during week 11 and 12 after the start of
infection. Ten days after the last injection, mice received OVA
aerosol challenges (10 mg/ml in PBS) for three consecutive days in
the 14th week of infection. Mice were sacrificed 24 hours after the
last challenge. BAL fluids were collected and phenotyped by flow
cytometry [8].
Study population
Venous blood was obtained from 20 school children living in
Lambare´ne´ (Gabon) or from a nearby village (PK15) where
Schistosoma haematobium is endemic. S. haematobium infection was
detected by examining 10 ml of urine passed through a 12-mm-
poresize filter (Millipore) and the eggs were stained with a
ninhydrin solution. Children were classified as ‘infected’ if at least
one S. haematobium egg was detected in the urine or ‘uninfected’ if
three consecutive urine samples were negative. Infections with
intestinal helminths A. lumbricoides, T. trichiura and hookworm were
determined by analyzing one fresh stool sample using the Kato-
Katz method [20]. Infection with P. falciparum was determined by
PCR [21]. S. haematobium-infected children were treated with three
doses of praziquantel (40 mg/kg) every two months. Intestinal
helminth and malaria infected children received respectively a
single dose of albendazole (400 mg) and an artemisinin-based
combination therapy as per the local guidelines.
Mouse cell purification and cell sorting
Single cell suspensions were prepared from the spleens,
mesenteric lymph nodes, and mediastinal lymph nodes by
dispersion through a 70-mm cell sieve (Becton Dickinson). Perfused
lungs were minced to ,1 mm pieces and digested by collagenase
II/Dnase for 1 hour. The digested lungs were sequentially
dispersed through 70- and 40-mm sieves. Erythrocytes were
removed from the spleen and lung single cell suspensions by lysis.
B cells were purified using anti-CD19 MicroBeads (Miltenyi
Biotec). Follicular B cells (CD21intCD23hi) and marginal zone B
cells (CD21hiCD23int/low) were stained with antibodies against
CD19-PE (MB19-1, eBioscience), CD21-APC (7G6, BD Pharmin-
gen), and CD23-FITC (B3B4, eBioscience) and separated using
FACSAriaII cell sorting (Becton Dickinson). The sorted subsets
were routinely ,95% pure. For the depletion of MZ B cells,
splenocytes were first incubated with CD19-PE (6D5, Miltenyi
Biotec), followed by anti-PE multisort beads (Miltenyi Biotec) to
isolate the B cells. Next, these beads were enzymatically removed
and the isolated B cells were incubated with CD21-FITC (7G6,
BD Pharmingen) antibody for 20 minutes. The CD21hi MZ B cell
fraction was depleted using anti-FITC magnetic beads (Miltenyi
Biotec). For the total CD19+ B cells, the CD21hi B cells were
added back to the CD21neg B cells (mock depletion). The depletion
of MZ B cells was ,92% pure. CD4+CD252 T cells were
enriched using anti-CD4 and anti-CD25 MicroBeads with a purity
of 96% (Miltenyi Biotec).
Human B cell isolation and characterization
PBMCs were isolated by Ficoll-Hypaque density gradient
centrifugation from 20 ml of heparinized blood. B cells were
isolated with anti-CD19 MicroBeads (Miltenyi Biotec) with a
purity of ,95%. For immunophenotyping different B cell subsets,
isolated PBMCs were fixed in 2.4% PFA and stained for CD19-PB
(HIB19, eBioscience), CD1d-PE (51.1, eBioscience), CD5-APC
(UCHT2, BD), CD24-PeCy7 (ML5, ITK Diagnostics), CD27-
APCeFluor780 (O323, eBioscience), and CD38-FITC (HIT2,
BD).
Adoptive transfer of isolated mouse B cells
Recipient mice were sensitized with two injections of OVA at
day 0 and day 7. Ten days after the last injection, the OVA-
sensitized animals received i.v. injection of 56106 pulmonary,
mesenteric, splenic total or splenic CD19+ B cells depleted for MZ
B cells from OVA sensitized-uninfected or OVA sensitized-
infected mice. Blocking anti-IL-10R antibody (250 mg; kindly
provided by Schering Plough Biopharma) or isotype control
antibody was given i.p., one day before adoptive transfer. DEREG
mice, which carry a Diphtheria toxin receptor-eGFP transgene
under the control of an additional Foxp3 promoter, were treated
with two diphtheria toxin (DT, 1 mg/ml) i.p. injections: one day
Helminth-Induced Mouse and Human CD1dhi Breg Cells
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before and two days after the adoptive transfer of B cells in order
to deplete the FoxP3+ Treg cells. After two days, mice were
challenged for three consecutive days and sacrificed 24 hours after
the last challenge.
In vitro mouse B cell stimulation and co-culture with
CD4+CD252 T cells
Mouse CD19+ B cells and B cell subsets (16105 cells) were
cultured in the presence of SEA from S. mansoni eggs (20 mg/mL)
for five days. Supernatants were stored for later cytokine analysis
by ELISA. For in vitro Treg induction, B cells (16105 cells) were
first irradiated with 2600 RAD and subsequently, co-cultured with
CD4+CD252 T cells (16105 cells) in the presence of medium or
anti-CD3 (1 mg/ml) plus anti-CD28 (1 mg/ml). An isotype control
anti-b-gal (10 mg/ml), or anti-IL-10 receptor (10 mg/ml) was
added. After five days, cells were fixed according to the
eBioscience FoxP3 fixation/permeabilization kit. Proliferation
was confirmed by cell counts. Cytokines were measured in the
cell culture supernatant using Luminex or ELISA (IL-1b,-4,-5,-6,
-10, -12p40/70, -13, IFN-c, TNF-a).
Human B cell stimulation and intracellular staining for IL-
10
Freshly isolated B cells (16105) were stimulated for 48 hours
with 2.5 mg/ml anti-human IgG/IgM (Jackson ImmunoRe-
search) in the presence or absence of 10 mg/ml SEA from S.
haematobium eggs. For ICS of IL-10, B cells were restimulated
with PMA (50 ng/ml), ionomycin (2 mg/ml), and LPS (100 ng/
ml; Invivogen) for 6 hours with the final 4 hours in the
presence of BrefA (10 mg/ml; Sigma-Aldrich), followed by
fixation with FoxP3 fixation/permeabilization kit and stained
for CD1d-PE (51.1, eBioscience), CD20-APCeFluor780 (2H7,
eBioscience), and IL-10-biotin (JES3-12G8, Abd Serotec)
followed by second incubation with streptavidin-Qdot525
(Invitrogen).
Statistical analysis
All murine results are expressed as mean 6 SEM and the
different groups were tested using the Student’s t-test (two-tailed).
Differences between infection groups in humans were tested by the
Mann-Whitney U test. Differences within the same group pre- and
post-treatment were compared by Wilcoxon matched pairs test.
Probability values less than 0.05 were considered significant.
*** p, 0.001, ** p,0.01, * p,0.05 and # p,0.1.
Results
IL-10-producing B cells are important for protection
against allergic airway inflammation
Elevated IL-10 characterizes chronic stages of schistosome
infection and is produced by B cells starting from week 12 during
infection (Fig. S1)[8]. To determine whether B cells are a
dominant source of IL-10 and whether this IL-10 is essential for
protection against AAI during chronic schistosome infections, IL-
10-deficient B cell and control wild-type (WT) chimeric mice
were generated and chronically infected with S. mansoni followed
by an allergic OVA sensitization and challenge. The IL-10-
deficiency was restricted to the B cells population (confirmed by
intracellular flowcytometry) as described before [10]. In the
uninfected allergic groups (OVA-uninfected) for both WT and
IL-102/2 B cell chimeric mice, the bronchoalveolar lavage (BAL)
fluid contained significantly more eosinophils (Fig. 1A), lympho-
cytes and macrophages compared to uninfected non-allergic
groups (PBS-uninfected) (data not shown). Nevertheless, in OVA-
infected WT mice significantly less eosinophils were found
compared to OVA-uninfected WT mice (Fig. 1A), as previously
described [8]. In contrast, eosinophilia in the OVA-infected
group of the IL-102/2 B cell mice was restored and was similar
to the OVA-uninfected IL-102/2 B cell group and significantly
higher compared to the OVA-infected WT group. Interestingly,
in the PBS-infected group, eosinophilia was equally high,
suggesting that IL-10-producing B cells were involved in
controlling non-allergic inflammatory processes during natural
infections as well. Furthermore, IL-5, IL-13 and/or IL-10 were
equally elevated in the BAL fluid and mediastinal lymph nodes
(MedLN) of OVA-infected IL-102/2 B cell mice compared to
OVA-uninfected IL-102/2 B cell group, whereas these Th2
cytokines were reduced in OVA-infected WT mice (Fig. 1B, C).
The IL-5 production in the BAL fluid and by T cells in the
MedLN was also significantly increased in the OVA-infected IL-
102/2 B cells mice compared to the OVA-infected WT mice as
well. As expected, IL-4 remained at low levels due to the C57/
Bl6 background of the chimeric mice (Fig. 1C). These results
indicate that IL-10-producing B cells are critically involved in the
downmodulation of eosinophilia and the Th2 response against
OVA antigen leading to protection against AAI during chronic
schistosomiasis.
Pulmonary and splenic B cells produce IL-10 and protect
against AAI
In order to identify the dominant organ with IL-10-producing
B cells during infection, we isolated B cells from organs that have
previously been described to harbor regulatory B cells (spleen),
drain schistosome infection sites (mesenteric lymph nodes, MLN)
or are the effector site where allergic inflammation is found (lung).
Both pulmonary and splenic B cells, but not mesenteric B cells,
from chronically-infected mice were able to produce IL-10 upon
soluble egg antigen (SEA) stimulation, with highest production by
splenic B cells (Fig. 2A). To study the suppressive activity of
isolated B cells from different organs in downmodulating AAI, we
adoptively transferred CD19+ B cells from OVA-infected mice
into OVA-sensitized recipient mice. AAI was reduced by
pulmonary or splenic but not by mesenteric B cells (Fig. 2B).
Interestingly, the protective effect of the transfer of splenic B cells,
but not of pulmonary B cells, was abolished by administering a
blocking IL-10 receptor antibody (Fig. 2C). Furthermore, we
observed increased percentages of CD4+CD25+FoxP3+ T cells in
the lungs of recipient mice, but only after administering splenic B
cells (Fig. 2D). This data indicate that pulmonary B cells can
drive IL-10 and Treg cell-independent protection against
eosinophilic AAI, while splenic B cells protect via an IL-10-
dependent mechanism and enhance local Treg cell numbers in
the lungs.
Splenic B cells induce Treg cells, which support reduction
of AAI
Regulatory B cells are known to regulate inflammation by
recruitment and generation of Treg cells in auto-immune disorders
[10]. Therefore, we cultured irradiated splenic B cells from OVA-
uninfected or OVA-infected mice with CD4+CD252 T cells from
naive mice to evaluate Treg cell development. Splenic B cells from
OVA-infected mice doubled the percentage of CD4+CD25+
FoxP3+Treg cells (Fig. 3A), while pulmonary B cells did not
change the level of Treg cells, as already confirmed in vivo. In
addition, no shift towards Th1 or Th2 cytokines was found during
the co-culture showing that the splenic B cells primarily influenced
Helminth-Induced Mouse and Human CD1dhi Breg Cells
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the development of Treg cells but not of other T cell subsets (data
not shown).
Next, we studied the contribution of B cell-induced Treg cells in
protection against AAI in vivo using OVA-sensitized FoxP3-DTR
transgenic DEREG mice [19]. The temporal loss of FoxP3+ Treg
cells during allergen challenge only partly restored AAI, showing
that in the group with transferred B cells from OVA-infected mice,
B cell-induced Treg cells are only partially involved in protection
against AAI (Fig. 3B).
A causal relationship between IL-10-producing B cells and Treg
cells has been suggested in antigen-induced arthritis model
utilizing similar chimeric mice, where loss of IL-10-producing B
cells led to significant reduction of Treg cells in draining inguinal
LN [22]. In OVA-infected WT mice, we found more
Figure 1. Role of IL-10-producing B cells on OVA-specific AAI during chronic S. mansoni infection. Chimeric WT and IL-102/2 B cell mice
were infected with S. mansoni and sensitized and challenged for OVA at week 11 and 12 after the start of infection. BAL fluid was collected and total
BAL cells (A) and eosinophils were determined. (B) In the BAL fluid, IL-5 and IL-13 were measured by ELISA. (C) MedLN cells were collected and
restimulated by OVA (10 mg/mL) for four days and IL-4, IL-5, IL-10, and, IL-13 production was determined using ELISA. Results are from two
independent experiments and each group consists of 6 PBS- and 6 OVA-uninfected, 8 PBS- and OVA-infected mice.
doi:10.1371/journal.pone.0030883.g001
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CD4+CD25+FoxP3+ Treg cells in the lung-draining MedLN
compared to OVA-uninfected mice, which was not found in
OVA-infected IL-102/2 B cell mice (Fig. 3C). Using the same in
vitro co-culture as describe above, significantly less Treg cell
induction by splenic B cells was found when anti-IL-10R
antibodies were added compared to isotype control (Fig. 3D),
underlining the role of IL-10 for Treg cell induction both in vivo
and in vitro.
Schistosome-induced MZ B cells exhibit regulatory
activities
We compared the two main splenic B cell subsets, the follicular
(FO) B cells and the MZ B cells (which are high in CD1d, Fig. S2)
for their ability to produce IL-10 during chronic infection. Sorted
subsets from uninfected and infected mice were cultured in the
presence of SEA, showing that the MZ B cells from infected mice
produced high IL-10 levels, while FO B cells produced only low
levels (Fig. 4A). Production of IL-12 and IL-1b remained low in
both subsets of infected mice, while production of TNF-a and IL-6
was increased in FO cells, but remained low in MZ B cells from
infected mice (Fig. S3). Based on our findings regarding Treg cell
induction by total splenic B cells, we questioned whether MZ B
cells, as the strongest IL-10 producers, were also responsible for
Treg cell induction in vitro. Therefore, irradiated FO and MZ B
cells were cultured with CD4+CD252 T cells and the highest
percentage of FoxP3+ T cells was observed in co-culture with MZ
B cells (Fig. 4B), which was not explained by differences in
proliferation as similar cell counts were found in cultures with
either FO or MZ B cells (data not shown). These data indicate that
MZ B cells are responsible for the regulatory features observed in
total splenic B cells by producing IL-10 and by enhancement of
FoxP3+ T cells.
Figure 2. IL-10 production by B cells from different organs during chronic schistosomiasis and their role in protection against AAI.
(A) WT mice were treated as in Fig. 1A. Splenic, pulmonary or mesenteric B cells (16105) were isolated and cultured in the presence of SEA (20 mg/ml)
for five days. IL-10 production was measured using ELISA and medium value was subtracted. (B) OVA-sensitized recipient mice received 56106 B cells
from different organs. After challenge, BAL cell numbers and eosinophils were determined (C) BAL numbers and eosinophilia of mice that received
250 mg isotype control or anti-IL-10R abs per mouse one day before the adoptive transfer. (D) The percentage of CD4+CD25+FoxP3+ Treg cells was
determined in the lungs of recipient mice. Each graph represents three independent experiments, consisting of five mice per group.
doi:10.1371/journal.pone.0030883.g002
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Next, the contribution of the MZ B cells in vivo was investigated
by depletion of the CD21hi cells from total splenic B cells of OVA-
uninfected or OVA-infected mice by indirect magnetic labeling
(Fig. 5A). The transfer of mock-treated B cells from OVA-infected
mice resulted in a decrease in total BAL cell count and
eosinophilia (Fig. 5B), as observed before. Importantly, the transfer
of CD21+-depleted B cells restored the severity of AAI and the
induction of pulmonary FoxP3+ Treg cells was lost (Fig. 5C),
confirming the significance of MZ B cells in protection against
AAI in vivo.
Elevated levels of IL-10-producing CD1dhi B cells in S.
haematobium-infected Gabonese children
All data regarding schistosome-induced Breg cells stems from
mouse models. Therefore, we asked whether in humans
schistosomes can also induce IL-10-producing regulatory B cells.
PBMC were collected from 20 Gabonese children that were either
S. haematobium positive or negative (Table 1). All samples were
simultaneously analyzed for different Breg markers, including
CD24hiCD38hi, CD24hiCD27+ or CD1dhi(CD5+) (Fig. 6A). No
differences were found between infected or uninfected donors for
CD24hiCD38hi or CD24hiCD27+ B cells (Fig. S4). However,
significantly higher percentage of CD1dhi B cells was found in
infected children compared to uninfected children (Fig. 6B). There
was also a trend for more CD1dhiCD5+ B cells in infected
children, however, the total numbers were so low (,1%) that the
reliability of this measurement can be questioned. Importantly,
after six months of treatment with praziquantel, CD1dhi
percentages were reduced to levels comparable to the uninfected
control group (Fig. 6B). Of note, CD1dhi levels in the uninfected
control group were significantly increased over the same period,
which may reflect seasonal changes. Alternatively, 6 out of 8
donors from the uninfected group had an increased population of
plasmablasts (CD19+CD24loCD38hi cells; Fig. S5), suggesting a
recent, unrelated infection in Lambare´ne´, but not in the nearby
village (,15 km, PK15), which may have caused the increase in
CD1dhi B cells observed in the uninfected children.
To compare the IL-10 production in B cells from infected and
uninfected children, total peripheral blood B cells were stimulated
with anti-IgG/IgM. Subsequent intracellular analysis showed an
increase in IL-10-producing B cells in the total B cell population of
infected children, which was significantly reduced after treatment
(Fig. 6A,C). Further gating on the CD1dhi B cell subset, confirmed
that in particular CD1dhi B cells from infected children produce
more IL-10 as compared to uninfected children (Fig. 6C).
Interestingly, we observed a slightly different pattern, when the
cells were stimulated with anti-IgG/IgM plus SEA (Fig. 6D).
Although also in this condition, both total and CD1dhi B cells from
infected children produce significantly more IL-10, this was not
downregulated upon treatment. This may reflect the presence of a
small, but persistent population of schistosome-specific B cells in
the circulation of previously infected children that more readily
produce IL-10 in response to SEA, as its cognate antigen,
compared to the more aspecific stimulation with antibodies
directed against IgG/IgM. Although it cannot be excluded that
SEA may also act as an adjuvant, this seems to be less likely as only
little IL-10 inducing activity of SEA is found in B cells from
uninfected children. The fact that somewhat elevated IL-10 levels
in anti-IgG/IgM plus SEA-stimulated B cells from uninfected
group at post-treatment are observed compared to pre-treatment
may again reflect seasonal effects or recent unrelated infections,
Figure 3. Treg cell induction by IL-10-producing Breg cells. (A)
Irradiated splenic B cells (16105) were cultured with CD4+CD252 T cells
(16105) for 5 days in the presence of anti-CD3 and anti-CD28. Induction
of CD4+CD25+FoxP3+ Treg cells (in %) by PBS-uninfected B cells was set
at one. Fold change in Treg cell percentage for OVA-uninfected and
OVA-infected B cells was calculated. Graph expresses results from three
independent experiments. (B) OVA-sensitized DEREG mice were treated
as in Fig. 2B in addition to a DT or PBS injection. This graph expresses
two experiments, consisting of five mice per group. (C) WT and IL-102/2
B cell chimeras were treated as in Fig. 1A. The MedLNs were collected
and the percentage of CD4+CD25+FoxP3+ Treg cells was determined.
Figure contains two independent experiments and each group consists
of 6 to 8 mice. (D) In vitro co-culture were performed as described in (A)
in the presence of blocking anti-IL-10R or isotype control antibodies.
Percentage of Treg cells induced in the presence of isotype control was
arbitrarily set at 1. Fold change in Treg cell induction in the presence of
anti-IL-10R was calculated. Graph represents three independent
experiments.
doi:10.1371/journal.pone.0030883.g003
Figure 4. MZ B cells show regulatory features. (A) MZ and FO B
cells from PBS-uninfected and PBS-infected were sorted using flow
cytometry and cultured for 5 days in the presence of SEA for IL-10
production as in Fig. 2A. (B) Irradiated MZ B cells or FO B cells (16105)
were co-cultured with CD4+CD252 T cells as described in Fig. 3A. Treg
cell induction by MZ or FO B cells from uninfected mice was set at one.
Subsequently, fold change in Treg cell induction by MZ or FO B cells
from OVA-uninfected and OVA-infected mice was calculated. Each
graph contains three independent experiments with five mice per
group.
doi:10.1371/journal.pone.0030883.g004
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suggested by the enhanced population of plasmablasts in this
group (Fig. S5).
Altogether, these data confirm that also in humans, schisto-
somes can induce IL-10-producing Breg cells, of which the CD1dhi
B subset is the most prominent. Therefore schistosomes can be
recognized as powerful Breg cell inducer in both mice and
humans.
Discussion
In this study we provide evidence that during chronic
schistosomiasis IL-10-producing CD1dhi B cells are induced in
both humans and mice. In mice, schistosome-induced IL-10-
producing Breg cells were necessary for protection against AAI as
shown here in chimeric IL-102/2 B cell mice. Splenic B cells were
the most prominent source for IL-10. Interestingly, the induction
of IL-10-producing splenic B cells by infectious agents has been
previously documented for L. major [12], murine cytomegalovirus
[23] and for Schistosoma mansoni by our group and by Amu et al [7].
These studies favor the concept that chronic infections, drive
strong immunoregulatory processes in which IL-10-producing B
cells seem to be important players (reviewed in [24]).
However, several reports have indicated that B cells can also
suppress inflammation via IL-10-independent mechanisms. In a
colitis model, mesenteric B cells were capable of reducing CD4+ T
cell-dependent colon inflammation [25] and mesenteric CD23hi B
cells of H. polygyrus-infected mice were capable of inhibiting
inflammation both in an EAE model and in an HDM-specific AAI
model via an unknown mechanism [26]. Furthermore, studies in S.
mansoni-infected mMT mice, where the lack of B cells led to
increased liver pathology have suggested the involvement of FcR-
dependent mechanisms [13]. Although their mode of action is still
unknown, we describe here that transferred pulmonary B cells also
protected against AAI independently of IL-10 and Treg cells. The
putative role of antibodies or interaction with FcR has not been
studied yet.
Further, we characterized the phenotype and function of the
dominant IL-10-producing B cell subset, finding a regulatory
Figure 5. MZ B cells are important in the protection against AAI. (A) Mock-depleted splenic and the MZ-depleted B cells were injected in
OVA-sensitized recipient mice. After challenge, total BAL cell count and the number of BAL eosinophils (B) and the percentage of CD4+CD25+FoxP3+ T
cells in the lungs (C) was measured. Figure is representative of two independent experiments, consisting of five mice per group.
doi:10.1371/journal.pone.0030883.g005
Table 1. Demographic characteristics and infection status of
Gabonese children.
S.h.
infected
S.h.
uninfected
Participants pre-tx/post-tx 10/7 10/8
Mean age in years (range) 10.3 (8–14) 11.2 (8–14)
Sex male/female 5/5 4/6
Mean egg counts (range) 31.7 (1–201) 0
Co-infections:
Plasmodium falciparum 4/10 1/10
Ascaris lumbricoides 3/9 3/8
Trichuris trichiura 3/9 6/8
Hookworm 1/9 1/8
Co-infections are depicted as number of participants infected out of total
number of participants tested.
doi:10.1371/journal.pone.0030883.t001
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function for CD1dhi MZ B cells in the spleen of schistosome-
infected mice. These data are in line with several other studies in
auto-immunity models pointing towards MZ B cells as regulators
of type 1 inflammation in SLE, ACAID or CHS [25,27]. In
addition, it was shown that CD1dhi-expressing splenic B cells
reduced inflammation in a chronic colitis model [25] and AAI
during ‘worm only’-schistosome infection [7]. However, within
the spleen, other regulatory subtypes have been suggested; a rare
CD1dhiCD5+ B cell subset, termed B10 cells, which are capable
of downregulating inflammatory responses in a number of
different auto-immune or contact hypersensitivity models [15]
and transitional type 2 MZ precursor B cells (CD21hiCD23-
hiIgMhi), described in mouse models for CIA [22,25] and SLE
[28]. It is not fully clear whether these B cells are complete
unique subsets because there is a substantial overlap between the
(co-)expression of various markers, such as CD1d, CD5, CD21,
CD23 and IgM. In addition, local inflammation or chronic
infection may change the expression of individual markers
complicating distinctions between the different proposed cell
subsets.
Here we show that helminth-induced MZ B cells not only
reduced allergic inflammation via IL-10 but also via the
induction/recruitment of active FoxP3+ Treg cells. In humans,
Treg cells are known to be an important element in reducing
allergic inflammation as a mutation in the FOXP3 gene is
associated with severe eczema, food allergy and high levels of IgE
and eosinophilia [29]. Furthermore, children with asthma show
quantitative and functional impairment of CD4+CD25+ Treg
cells in the BAL fluid [30], while children that have outgrown
their allergy have increased frequencies of allergen-responsive
Treg cells [31,32]. Therefore, having a system that embraces not
only one regulatory system but in fact two seems to be a very
efficient strategy to develop tolerance to environmental stimuli
and prevent allergy. Indeed, in several studies Breg function has
been linked to induction or recruitment of Treg cells, i.e. in a
model of ACAID, colitis, EAE, SLE [24,25] and allergic
inflammation [7]. Importantly, in these studies including the
one presented here, Breg-induced immune regulation does not
fully depend on Treg cell activity, with the exception of the study
by Amu et al. [7], where in fact an excess of regulatory CD1dhi B
cells was transferred to recipient mice on three consecutive days,
in contrast to our study with only one B cell injection before the
challenge.
Although the majority of studies on Breg cells have been
conducted in mouse models there are now a few reports that
confirm the existence of human Breg cells, in which both
equivalents of already described ‘mouse’ Breg cells are identified
in addition to some new subsets. Correale et al. have reported
human IL-10-producing CD1dhi B cells in helminth-infected MS
patients [18]. However, these patients were infected with a
mixture of different helminth species. Here, we now have
established a causal relation between a single species of helminth,
schistosomes and increased levels of IL-10-producing CD1dhi B
cells, which were reduced to ‘normal’ levels after anti-schistosome
treatment. Of note, in both schistosome-infected and uninfected
children, other geohelminths were found and for ethical reasons
both groups were treated with the antihelmintic albendazole in
addition to treatment with praziquantel for the schistosome-
infected group. Despite their initial presence, we find reduced
numbers of CD1dhi B cells after treatment only in the schistosome-
infected group but not in the schistosome-uninfected group. These
data suggest that schistosomes have a more dominant effect on
Breg cell induction than other gut-associated helminths. So far,
two other human Breg subsets have been described, namely
Figure 6. Presence of IL-10-producing CD1dhi B cells during S.
haematobium (S.h.) infection. (A) The CD1dhi B cells and the IL-10
production of the total B cells were gated according to the gating
strategy depicted in this graph. The gating of the IL-10 production of
the different Breg subsets is similar as the total B cell gating. (B) PBMC
were fixed and stained for Breg markers, including CD1d, and analyzed
by flow cytometry. (C) Total peripheral blood B cells were cultured with
anti-IgG/IgM or (D) anti-IgG/IgM plus SEA (10 mg/ml) for two days.
Intracellular IL-10 production of the total B cells and the CD1d+ B cells
was determined following PMA/Ionomycin/LPS and BrefA stimulation.
doi:10.1371/journal.pone.0030883.g006
Helminth-Induced Mouse and Human CD1dhi Breg Cells
PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e30883
CD24hiCD27+[17] and CD24hiCD38hi Breg cells in healthy
individuals, of which the activity of the latter was impaired in
SLE patients [16]. Interestingly, we did not observe differences in
these two Breg cell subsets in peripheral blood of infected versus
uninfected children, indicating that schistosomes primarily induce
CD1dhi Breg cells. This discrepancy suggests that the various Breg
cell subsets described so far may require different conditions for
their development and activation.
As illustrated above, evidence from animal studies and a few
human studies points towards a significant role for IL-10-
producing Breg cells in modulating pathogenic hyperinflammatory
responses. As such, it would be of great therapeutic interest if Breg
cell activity could be specifically induced. For this, helminth
infections may be of particular value, as in vitro exposure of splenic
B cells to live schistosome worms or peritoneal injection of
schistosome egg-derived glycans or filarial glycoproteins induces
IL-10-producing B cells [7,33]. However, the identification of the
exact helminth-derived molecules involved, is a critical step as
enhanced activity of Breg cells may form a valuable new target for
therapy of rhinitis and/or allergic asthma.
Supporting Information
Figure S1 IL-10 production by CD19+ B cells during
infection. Mouse CD19+ B cells were isolated from the spleen at
different time points during Schistosoma mansoni infection. The B
cells were cultured in the presence of SEA from S. mansoni eggs
(20 mg/mL) for five days. Supernatants were stored for IL-10
analysis by ELISA. This experiment represents one experiment
with 3–4 mice per group.
(TIF)
Figure S2 Geometric mean of CD1d fluorescence inten-
sity on total B cells, FO and MZ B cells.
(TIF)
Figure S3 Production of cytokines after SEA stimula-
tion. MZ and FO B cells from PBS-uninfected and PBS-infected
were sorted using flow cytometry and cultured for five days in the
presence of SEA for IL-10 production as presented in Fig. 2A. In
addition, we measured IL1-b, IL-12p40/70, IL-6 and TNF-a
using Luminex.
(TIF)
Figure S4 Percentage of CD24hiCD38hi. and CD24hi
CD27+ B cells in peripheral blood of Gabonese children
pre- and post-treatment, performed as described in
legend to Fig. 6B.
(TIF)
Figure S5 Percentage plasmablasts in peripheral blood
of Gabonese children pre- and post-treatment, per-
formed as described in legend to Fig. 6B.
(TIF)
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